227 related articles for article (PubMed ID: 32592798)
1. Contemporary hormonal contraception and risk of endometrial cancer in women younger than age 50: A retrospective cohort study of Danish women.
Iversen L; Fielding S; Lidegaard Ø; Hannaford PC
Contraception; 2020 Sep; 102(3):152-158. PubMed ID: 32592798
[TBL] [Abstract][Full Text] [Related]
2. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
3. Contemporary Hormonal Contraception and the Risk of Breast Cancer.
Mørch LS; Skovlund CW; Hannaford PC; Iversen L; Fielding S; Lidegaard Ø
N Engl J Med; 2017 Dec; 377(23):2228-2239. PubMed ID: 29211679
[TBL] [Abstract][Full Text] [Related]
4. Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.
Jareid M; Thalabard JC; Aarflot M; Bøvelstad HM; Lund E; Braaten T
Gynecol Oncol; 2018 Apr; 149(1):127-132. PubMed ID: 29482839
[TBL] [Abstract][Full Text] [Related]
5. Contemporary hormonal contraception and cervical cancer in women of reproductive age.
Iversen L; Fielding S; Lidegaard Ø; Hannaford PC
Int J Cancer; 2021 Apr; ():. PubMed ID: 33818778
[TBL] [Abstract][Full Text] [Related]
6. Hormonal contraceptive use and risk of pancreatic cancer-A cohort study among premenopausal women.
Butt SA; Lidegaardi Ø; Skovlund C; Hannaford PC; Iversen L; Fielding S; Mørch LS
PLoS One; 2018; 13(10):e0206358. PubMed ID: 30376560
[TBL] [Abstract][Full Text] [Related]
7. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
Iversen L; Sivasubramaniam S; Lee AJ; Fielding S; Hannaford PC
Am J Obstet Gynecol; 2017 Jun; 216(6):580.e1-580.e9. PubMed ID: 28188769
[TBL] [Abstract][Full Text] [Related]
8. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
Lidegaard O; Nielsen LH; Skovlund CW; Løkkegaard E
BMJ; 2012 May; 344():e2990. PubMed ID: 22577198
[TBL] [Abstract][Full Text] [Related]
9. Association of Hormonal Contraception With Depression.
Skovlund CW; Mørch LS; Kessing LV; Lidegaard Ø
JAMA Psychiatry; 2016 Nov; 73(11):1154-1162. PubMed ID: 27680324
[TBL] [Abstract][Full Text] [Related]
10. Ovarian reserve markers in women using various hormonal contraceptives.
Landersoe SK; Forman JL; Birch Petersen K; Larsen EC; Nøhr B; Hvidman HW; Nielsen HS; Nyboe Andersen A
Eur J Contracept Reprod Health Care; 2020 Feb; 25(1):65-71. PubMed ID: 31852271
[No Abstract] [Full Text] [Related]
11. Hormonal contraception and risk of venous thromboembolism: national follow-up study.
Lidegaard Ø; Løkkegaard E; Svendsen AL; Agger C
BMJ; 2009 Aug; 339():b2890. PubMed ID: 19679613
[TBL] [Abstract][Full Text] [Related]
12. Ovarian and endometrial function during hormonal contraception.
ESHRE Capri Workshop Group
Hum Reprod; 2001 Jul; 16(7):1527-35. PubMed ID: 11425842
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
14. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives and breast cancer risk among younger women.
Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
[TBL] [Abstract][Full Text] [Related]
16. Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis.
Fitzpatrick D; Pirie K; Reeves G; Green J; Beral V
PLoS Med; 2023 Mar; 20(3):e1004188. PubMed ID: 36943819
[TBL] [Abstract][Full Text] [Related]
17. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.
Collaborative Group on Hormonal Factors in Breast Cancer
Lancet; 1996 Jun; 347(9017):1713-27. PubMed ID: 8656904
[TBL] [Abstract][Full Text] [Related]
19. Former long-term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: A prospective, population-based cohort study.
Mosorin ME; Ollila MM; Nordström T; Jokelainen J; Piltonen T; Auvinen J; Morin-Papunen L; Tapanainen J
Acta Obstet Gynecol Scand; 2023 Nov; 102(11):1488-1495. PubMed ID: 37568273
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947-1964: The Nurses' Health Study II, a prospective cohort study.
Burchardt NA; Shafrir AL; Kaaks R; Tworoger SS; Fortner RT
Eur J Epidemiol; 2021 Aug; 36(8):827-839. PubMed ID: 33331993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
